What to Expect When Nike, Inc. Reports Earnings The

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

What to Expect When Nike, Inc. Reports Earnings
The footwear and athletic apparel giant is set to offer quarterly results next week. Here's what investors need to know.
Steve Symington
(TMFSymington)
Dec 15, 2015 at 12:40PM
Nike

Lace up your sneakers, Nike (NYSE:NKE) investors, because the sportswear behemoth is poised to announce fiscal second-quarter 2016 results next Tuesday after the bell. And with Nike stock up more than 30% year to date on the heels of its impressive fiscal Q1 report three months ago, you can bet investors will be listening closely to what it says.

But what, exactly, should we be listening for when Nike's report crosses the wires?

The currency factor
First, Nike's reported results are somewhat deceiving given the outsized role foreign currency exchange has played in holding back reported growth in recent quarters. International markets consistently represent more than half of all NIKE Brand sales. So last quarter, while Nike's revenue climbed just 5% year over year to $8.4 billion, it would have jumped a much more impressive 14% if it weren't for the negative impact of foreign currency exchange.

For perspective, Under Armour's (NYSE:UA) International revenue only comprised 11% of its own total last quarter, which meant a comparatively minor three percentage point difference between Under Armour's reported growth (at 28%) and currency-adjusted growth (at 31%). At the same time, Under Armour's international sales also skyrocketed 51% year over year last quarter as the smaller athletic apparel specialist continues to invest heavily to expand its global reach. So while Under Armour's overall results should gradually grow to more closely resemble those of Nike in terms of currencies, Nike investors would be wise to keep an eye on whether Under Armour is taking ground in the overseas markets it chooses to enter.

In the meantime, Nike's current fiscal Q2 guidance calls for reported revenue growth in the mid-single-digit percentage range, and currency-neutral growth in the low teens. But more than anything, these currency headwinds should prove a temporary burden and aren't indicative of deeper problems with Nike's underlying business.

In addition, Nike simultaneously expects gross margin this fiscal year to expand by around 50 basis points, including a more modest 25-basis-point expansion this quarter as it works to efficiently clear excess inventory and keep in-line channels as fresh as possible. As Nike works to improve operational efficiency while these economic headwinds persist, it should emerge even stronger in the end.

Broad global strength
To be sure, Nike's performance on a geographic basis has been nothing short of remarkable. After suffering uncertainty as it reset its business in China last year, then encountered difficult comps as it lapped an exceptional quarter following last year's FIFA World Cup, last quarter Nike achieved double-digit currency-neutral growth in every geography except North America, where currency-neutral revenue rose a still-solid 9%. Greater China, in particular, saw a 30% increase in revenue last quarter despite ongoing macroeconomic challenges in the region.

Investors should also hope for continued strength in Nike's direct-to-consumer (DTC) business. That includes overall DTC revenue (up 21% year over year last quarter), which itself should be driven by a combination of new stores, growth in online sales at Nike.com (up 46% last quarter), and comparable store sales growth (up 7% last quarter).

Meanwhile, don't forget about Converse, the smaller sneaker brand Nike acquired for only $305 million in 2003. Last quarter, Converse sales actually fell 3% year over year to $555 million, or less than 7% of Nike's total revenue, and only rose 3% excluding currencies. Once again, however, looks can be deceiving: Nike management explained during last quarter's conference call that Converse is still enjoying double-digit growth here in the United States. And going forward, Converse's quarterly year-over-year comparisons will likely be lumpy as Nike transitions the brand to a "more direct operating model" outside the U.S.

Running forward
Finally, in addition to the usual top-line and gross margin revenue guidance, Nike management should give investors a supplementary glimpse to the month's ahead with details on scheduled worldwide futures orders. For perspective, Nike most recently stated last quarter's futures orders were 9% higher than the same year-ago period, 17% higher excluding currencies, and more heavily weighted toward the second half of the five-month period ending January 2016. This quarter's futures orders should span the five-month period between December 2015 and April 2016, and give investors a fresh look at how Nike believes it will fare for the first third of the coming calendar year.

In the end, however, if Nike's past performance is any indication, I suspect this will prove yet another solid report as Nike implements its long-term plans to continue creating shareholder value.

There's something big happening this Friday

I don't know about you, but I always pay attention when one of the best growth investors in the world gives me a stock tip. Motley Fool co-founder David Gardner (whose growth-stock newsletter was the best performing in the world as reported by The Wall Street Journal)* and his brother, Motley Fool CEO Tom Gardner, are going to reveal their next stock recommendations this Friday. Together, they've tripled the stock market's return over 12+ years. And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their ideas.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 8

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Imaging Techniques for Lung Cancer Treatment Success

Updated Category News Views 37

Revolutionary Techniques in Lung Cancer Management Onc.AI, a leading digital health innovator, is making strides in oncology clinical management with its pioneering approach toward imaging in advanced non-small cell lung cancer (NSCLC). The company focuses on integrating artificial intelligence into healthcare to enhance patient survival rates in cancer treatments....

Continue Reading
Kane Biotech Secures Funding Through Private Placement Initiative

Updated Category News Views 173

Kane Biotech Achieves Significant Milestone with Recent Funding Kane Biotech Inc. has recently made headlines by completing the first closing of its exciting non-brokered private placement offering. This strategic move is set to enhance the company’s capacity to innovate and expand its market presence. Private Placement Offering Details Under this newly announced...

Continue Reading
Apple Adjusts iPhone Air Production Amidst Strong Demand Shift

Updated Category News Views 183

Apple's Strategic Shift in iPhone Production Apple Inc. (NASDAQ:AAPL) has made a significant decision to decrease production orders for its iPhone Air while ramping up production for other flagship models like the iPhone 17. This change comes amid a surge in demand for these devices, particularly in markets that are seeing stronger consumer engagement. Weak Demand Impacts...

Continue Reading
Navigating Legal Proceedings: Insights for RxSight Investors

Updated Category News Views 273

A Comprehensive Guide for RxSight Investors Amid Legal Concerns Investors in RxSight, Inc. should be aware of the growing legal challenges facing the company. Robbins Geller Rudman & Dowd LLP is leading a class action lawsuit aimed at representing those who have faced significant financial losses while investing in RxSight (NASDAQ: RXST). This article delves into the...

Continue Reading
Reusable Laryngoscope System Market Growth Projections for 2034

Updated Category News Views 120

Tremendous Growth in the Reusable Laryngoscope System Market The reusable laryngoscope system market is on track for significant expansion, currently valued at around $920 million in the near term. With the healthcare industry increasingly leaning towards efficient and cost-effective solutions, this market is projected to reach approximately $1.8 billion by the year 2034....

Continue Reading